Marta Winnes

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma

Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor

Notch signalling in solid tumours: a little bit of everything but not all the time

ETS gene fusions in prostate cancer

Glutathione peroxidases

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery

The causes and consequences of genetic heterogeneity in cancer evolution

The complexity of prostate cancer: genomic alterations and heterogeneity

Signatures of Archaic Adaptive Introgression in Present-Day Human Populations

Recurrent gene fusions in prostate cancer

Sarcoma molecular testing: Diagnosis and prognosis

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors

A fourth Denisovan individual

Analysis of chromosome 10 aberrations in rat endometrial cancer—evidence for a tumor suppressor locus distal to Tp53

Clear cell hidradenoma of the skin—a third tumor type with a t(11;19)‐associated TORC1–MAML2 gene fusion

Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogene

Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas

Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer